Virtus Fund Advisers’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$348K Buy
+4,411
New +$348K ﹤0.01% 410